The long term oxygen treatment trial demonstrated that long term supplemental oxygen did not reduce time to hospital admission or death for patients who have stable chronic obstructive pulmonary disease and resting and or exercise induced moderate oxyhemoglobin desaturation nor did it provide benefit for any other outcome measured in the trial. Chronic obstructive pulmonary disease copd is a leading cause of disability and death globally characterised by progressive breathlessness loss of function and in its later stages chronic hypoxaemia long term continuous oxygen therapy increases life expectancy in patients with severe resting hypoxaemia. Technology long term oxygen therapy is extended use of oxygen oxygen therapy is delivered as a gas from an oxygen source different oxygen sources are 1 oxygen concentrators electrical units delivering oxygen converted from room air 2 liquid oxygen systems which deliver gaseous oxygen stored as liquid in a tank and 3 oxygen cylinders which contain compressed gaseous oxygen. The national heart lung and blood institute nhlbi and the centers for medicare and medicaid services cms today announced the publication of the long awaited results from the long term oxygen treatment trial lott in the new england journal of medicine a pplong term oxygen treatment has already been shown to improve survival and reduce hospitalizations in those with copd and severely. A newly published study of people with chronic obstructive pulmonary disease copd concludes that long term supplemental oxygen treatment results in little or no change in time to death time to first hospitalizations or significant quality of life improvements for those with moderately low blood oxygen levels
How it works:
1. Register a Free 1 month Trial Account.
2. Download as many books as you like ( Personal use )
3. No Commitment. Cancel anytime.
4. Join Over 100.000 Happy Readers.
5. That's it. What you waiting for? Sign Up and Get Your Books.